AlgoCovid - Survey on pain and discomfort among Covid-19 patients

Head :
LAFON Benoît

Last update : 04/23/2021 | Version : 1 | ID : 73972

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Survey on pain and discomfort among Covid-19 patients
Sign or acronym AlgoCovid
General Aspects
Medical area Infectious diseases
Study in connection with Covid-19 Yes
Pathology (details) Covid-19
Scientific investigator(s) (Contact)
Name of the director LAFON
Surname Benoît
Email lafonb@ch-blois.fr
Collaborations
Funding
Governance of the database
Sponsor(s) or organisation(s) responsible LDPD
Organisation status
Additional contact
Main features
Type of database
Type of database Study databases
Database objective
Main objective This “Survey on pain and discomfort among Covid-19 patients” aims to develop our knowledge on acute pain in the course of the Covid-19 disease, together with pain and discomfort persisting after the acute phase of the disease

Secondary objectives:
• Determine the location and type of pain, together with pain intensity, number of different painful syndromes during and after the acute phase of the disease.
• Determine the specific prevalence of each painful syndrome identified, notably the prevalence of neuropathic pain.
• Determine the components causing residual discomfort.
• The endpoints, for each parameter measured, are the rate of positive answers in the corresponding existing sections (specific columns in the data collection table) or the rate of positive answers in the sections created during the analysis (calculation columns added, to meet objectives combining several existing sections).
Inclusion criteria Eligibility criteria:
• Male or female adult subject (18 years or over)
• AppliSamu record stating code VIN02, VIN03 or VIN06 between 01/03 and 31/05/2020
Inclusion criteria:
• Answering the telephone call (three attempts maximum)
• Patient’s verbal agreement to a telephone interview
• Covid-19 disease confirmed by one of the following conditions:
- AppliSamu code VIN06 (= confirmed Covid-19)
- Code VIN02 or VIN03 (= suspected Covid-19) and patient confirming their positive diagnosis (by PCR, CT scan or appointment with an infectious diseases specialist)
Population type
Age Adolescence (13 to 18 years)
Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Pathology R52 - Pain, not elsewhere classified
Gender Male
Woman
Geography area Local
Data collection
Dates
Size of the database
Size of the database (number of individuals) [1000-10 000[ individuals
Details of the number of individuals 1000
Data
Type of data collected Declarative data
Declarative data (detail) Phone interview
Procedures
Followed pathology
Promotion and access
Promotion
Access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05